IceCure Medical Ltd (ICCM)

IceCure Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	12.03	8.9	7.56	10.53	23.66	25.62
Short-Term Investments	-	-	-	0.53	-	-
Cash & Short-Term Investments	12.03	8.9	7.56	11.06	23.66	25.62
Cash Growth	123.56%	17.62%	-31.62%	-53.24%	-7.66%	213.56%
Accounts Receivable	0.41	0.33	0.22	0.1	0.08	0.46
Other Receivables	-	0.21	0.19	0.13	0.29	0.32
Receivables	0.41	0.54	0.41	0.23	0.37	0.77
Inventory	2.55	2.63	1.99	2.28	2.86	1.96
Prepaid Expenses	1.65	0.24	0.66	0.51	0.61	1.8
Other Current Assets	-	0.3	0.14	0.11	0.64	0.18
Total Current Assets	16.65	12.61	10.75	14.18	28.13	30.32
Property, Plant & Equipment	1.01	1.23	1.78	2.19	2.02	1.63
Other Long-Term Assets	0.05	0.05	0.05	0.03	0.03	0.33
Total Assets	17.71	13.89	12.58	16.41	30.19	32.28

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.63	0.86	1.23	0.5	0.71	0.88
Accrued Expenses	3.19	3.5	3.65	2.96	2.81	2.03
Current Portion of Leases	0.07	0.2	0.3	0.22	0.17	0.22
Current Unearned Revenue	-	0.26	0.33	0.19	0.65	0.88
Other Current Liabilities	0.9	-	-	-	-	-
Total Current Liabilities	5.79	4.82	5.51	3.87	4.34	4.02
Long-Term Leases	0.02	0.01	0.16	0.38	0.43	0.69
Other Long-Term Liabilities	-	-	-	-	-	0.62
Total Liabilities	5.81	4.84	5.68	4.25	4.77	5.32

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Additional Paid-In Capital	141.11	129.49	112.28	102.22	100.83	85.39
Retained Earnings	-129.21	-120.44	-105.38	-90.06	-75.41	-58.43
Shareholders' Equity	11.9	9.05	6.9	12.16	25.42	26.96
Total Liabilities & Equity	17.71	13.89	12.58	16.41	30.19	32.28

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.09	0.22	0.46	0.6	0.6	0.91
Net Cash (Debt)	11.94	8.68	7.11	10.46	23.06	24.71
Net Cash Growth	296.42%	22.17%	-32.09%	-54.63%	-6.68%	215.24%
Net Cash Per Share	4.71	4.10	4.19	6.88	18.69	25.97
Filing Date Shares Outstanding	3.43	2.44	1.89	1.52	1.52	1.19
Total Common Shares Outstanding	3.43	2.44	1.89	1.52	1.52	1.19
Working Capital	10.86	7.78	5.24	10.31	23.79	26.3
Book Value Per Share	3.47	3.71	3.66	7.98	16.72	22.60
Tangible Book Value	11.9	9.05	6.9	12.16	25.42	26.96
Tangible Book Value Per Share	3.47	3.71	3.66	7.98	16.72	22.60
Machinery	-	2.59	2.59	2.52	2.06	0.88
Leasehold Improvements	-	0.21	0.21	0.21	0.21	0.13

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 29, 2026

Data Sources Report a data error